首页> 外文期刊>Journal of biomedical nanotechnology >Enhanced Oral Bioavailability and Absorption Mechanism Study of N3-0-Toluyl-Fluorouracil-Loaded Liposomes
【24h】

Enhanced Oral Bioavailability and Absorption Mechanism Study of N3-0-Toluyl-Fluorouracil-Loaded Liposomes

机译:增强N3-0-甲苯氟尿嘧啶脂质体的口服生物利用度和吸收机制研究

获取原文
获取原文并翻译 | 示例
           

摘要

The present investigation attempts to increase oral absorption of N3-O-Toluyl-Fluorouracil (TFu), one of the new and effective 5-fluorouracil prodrugs, by employing liposomal techniques TFu-loaded liposomes with different sizes all resulted in higher bioavailabilities than TFu aqueous suspensions after oral administration, and the gastrointestinal absorption increased with the reduction of lipo-some sizes In order to investigate the enhancing absorption mechanism of TFu-loaded liposomes, the everted gut sac experiments were applied to examine the influences of different factors. It was found that the uptake increased linearly with the concentration of TFu while the intestinal permeability coefficients changed slightly and the absorption process fitted with the Fick's diffusion law in the range of 5~20 /xg mL~1. The oral absorption of TFu-loaded liposomes might be a non-carrier-mediated and energy-independent, passive transport way. The liposomal bilayer was not stable enough and proned to be degraded partly in gastrointestinal tract (drug entrapment efficiency reduced by 5%~17%). The comparative studies between TFu-loaded liposomes and TFu solid lipid dispersions indicated that the two formulations had the same effects on enhancing the oral absorption of TFu. It could be concluded that it was the free drug but not the intact liposomes that penetrated the intestinal wall; the increased affinity between TFu-loaded liposomes and the gut liquid caused better dispersion of TFu in the gastrointestinal tract, prolonged the drug residence time in the absorption sites and resulted in better absorption effects. The decreasing liposomes sizes resulted in an increase in surface area, saturation solubility and consequently, and an increase in the bio-adhesion to the gastrointestinal tract wall thus increasing the oral bioavailability.
机译:本发明的研究试图通过使用脂质体技术TFU加载的脂质体具有不同尺寸的脂质体技术,增加了新的和有效的5氟尿嘧啶前药之一的口服吸收。从而产生比TFU水性更高的生物脂肪酸口服给药后的悬浮液,胃肠道吸收随着脂肪的还原而增加,以研究加载TFU加载脂质体的增强机制,应用了EVERED肠道囊实验以检查不同因素的影响。发现摄取与TFU的浓度线性增加,而肠道渗透系数略微发生变化,并且吸收过程配有FIC在5〜20 / xg ml〜1的范围内的偏移量。加载TFU加载的脂质体的口服吸收可能是非载体介导和无关的无源被动的传输方式。脂质体双层不够稳定并分解在胃肠道中的降解(药物滞留效率降低5%〜17%)。加载TFU脂质体和TFU固体脂质分散体之间的比较研究表明,两种制剂对增强TFU的口腔吸收具有相同的影响。可以得出结论,它是免费的药物,但不是穿透肠壁的完整脂质体;在胃肠道中提高TFU与肠道之间的亲和力增加,延长了吸收部位的药物停留时间,使药物停留时间延长,导致更好的吸收效应。降低脂质体尺寸导致表面积,饱和溶解度的增加,因此,对胃肠道壁的生物粘合性的增加,因此增加了口腔生物利用度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号